Connect with us

Cannabis

AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia

Published

on

Photo source: royalqueenseeds.com

 

AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) (“TLV”) has granted an import licence for cannabis products for medical purposes for Germany according to Section 72 of the German Medicine Law (Arzneimittelgesetz – AMG) to Alternative Medical Products GmbH (“AMP Germany”), a wholly-owned subsidiary of AMP.

The TLV deals with fundamental matters of economic consumer protection and consumer policy for the Free State of Thuringia in Germany.

The import license allows AMP to import medical cannabis purchased from outside the European Union into Germany.  Once imported into Germany, AMP sells the European Union-Good Manufacturing Practices (EU-GMP) medical cannabis flower to pharmaceutical distributers who supply to German pharmacists.  AMP’s supply chain across Germany is currently being EU-GMP audited to ensure the quality and integrity of the medical cannabis is maintained during transportation, warehousing, testing and distribution.  This audit should be successfully finalized before year-end.

AMP has entered into supply agreements to purchase collectively 2,400 kg of EU-GMP medical cannabis annually from two producers once they have obtained their Health Canada sales license and received EU-GMP certification from TLV.  AMP has entered into a multi-year distribution agreement for the sale of 1,200 kg annually in the first year of EU-GMP medical cannabis with a German pharmaceutical distributor.  AMP anticipates entering into additional supply and pharmaceutical distribution agreements before year-end.

Dr. Stefan Feuerstein, Managing Director of AMP Germany, commented, “AMP receiving its import license according to § 72 AMG (German Medicine Law) after a stringent audit is an important step to be fully capable to import EU-GMP medical cannabis into Germany.”

Mr. Alex Blodgett, CEO of AMP, commented, “AMP has put all the pieces together for it to be one of the first significant importers of medical cannabis to Germany that is not involved in cultivation.  In the near future, we plan to enter into additional supply agreements for EU-GMP medical cannabis for the growing German market from international partners.”

 

SOURCE AMP German Cannabis Group Inc.

Cannabis

Hemp, Inc. Announces Significant Progress in Hemp Seed Meal Approval for Laying Hen Diets

Published

on

Continue Reading

Cannabis

Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors

Published

on

Continue Reading

Cannabis

The Blinc Group Reveals “Bijou”: A Leap Forward in Cannabis Vaping Technology

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania